MEDNAX, Inc. (MD - Free Report) and its subsidiary MEDNAX Radiology Solutions recently introduced the MEDNAX Radiology Solutions Artificial Intelligence (MDR-AI) Incubator. The launch combines radiologists, a rich collection of clinical data and a chosen group of technology partners, concertedly focusing on product development in radiology to lead to more accurate and quality patient care.
Currently, there are a total of 15 active partners at different levels of engagement, adding value via production usage of present models within the MEDNAX Radiology Common Imaging Platform. With the help of its evolving network, MEDNAX Radiology Solutions has been successful in building an ecosystem made of enriched and diverse accumulation of data with AI-based natural language processing, smooth reach to the leading practice of radiologists and the capability of validating models on a national range.
The MDR-AI Incubator aims at building innovative tools in a protected space and thus, congregates companies of all sizes so that they can invent unique tools to boost the application of radiology for the betterment of patients. MEDNAX Radiology Solutions and Virtual Radiologic (vRad) have together worked toward a focused clinical and technical collaboration with the main intension of growing patient outcomes.
At the moment, MEDNAX Radiology Solutions caters to more than 2100 hospitals, health systems and clinics plus imaging centers across the nation. It specializes in providing personalized and comprehensive solutions, which are proved to drive growth and create value.
The parent company has been constantly focusing on expanding its radiology organization through buyouts. The first half of 2018 witnessed almost double revenues from the radiology organization, mainly aided by accretive acquisitions. In October 2018, the company even closed the pending purchase of Radiology Specialists, LTD, a private radiology physician group based in Las Vegas.
Shares of this Zacks Rank #3 (Hold) company have lost around 20.6% in a year’s time against its industry’s rally of 45.7%.
Stocks to Consider
Investors interested in the medical sector might take a look at some better-ranked stocks like Aetna Inc. , Molina Healthcare, Inc (MOH - Free Report) and Anthem, Inc. (ANTM - Free Report) .
Aetna operates as a health care benefits company in the United States. It carries a Zacks Rank #2 (Buy) and managed to pull off average four-quarter positive surprise of 7.33%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Molina provides Medicaid-related solutions to meet the health care needs of low-income families and individuals. Plus, it assists state agencies in the administration work of the Medicaid program across the United States. Sporting a Zacks Rank #1, the stock delivered average four-quarter beat of nearly 82.55% in the last four reported quarters.
Anthem operates as a health benefits company in the United States. It carries a Zacks Rank of 2 and managed to come up with average four-quarter earnings surprise of 5.11%.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Click here for the 6 trades >>